Patent application number | Description | Published |
20080300286 | Tyrosine Derivatives Substituted By N-Arylacryloyl as Agonists of Hppar Alpha and/or Hppar Gamma - The present invention relates to a compound of formula I, racemates, optically active isomers, or pharmaceutically acceptable salts or solvates thereof, and a pharmaceutical composition comprising the compound, the various radicals in the formula I are the same as defined in the claims. The present invention also relates to a process for preparing the compound of formula I and use of said compound in the preparation of a medicament for the treatment of hyperglycemia, dyslipidemia, type II diabetes mellitus including associated diabetic dyslipidemia | 12-04-2008 |
20090176877 | OSELTAMIVIR PHOSHATE GRANULE AND PREPARATION METHOD THEREOF - The present invention relates to an oseltamivir phosphate granule and preparation method thereof. The said granule comprises 1.97-19.8 wt. % oseltamivir phosphate, 75.0-97.5 wt. % diluent, 0.1-5.0 wt. % binder, optionally 1.0-5.0 wt. % edible flavouring essence, sweetener and/or edible pigment. It is prepared by using 30-55 v/v % aqueous ethanol solution as moistening agent. The granules prepared by the formulation and method according to the present invention have good uniformity and stability and are water-soluble. The administration dosage of the granules can be conveniently selected based on the age and body weight of patients. The oseltamivir phosphate granule is suitable for administering to old people, children and flu gravis patients and those patients that swallow inconveniently or difficulty. The preparation of the granule is simple and low in production cost. | 07-09-2009 |
20100004268 | Optically Pure Dihydropyrimidine Compounds and Their Uses for the Preparation of a Medicament for Treatment and Prevention of Viral Diseases - The present invention relates to an optically pure compound of formula (I) or a pharmaceutically acceptable salt or hydrate thereof, a process for preparing the optically pure compound of formula (I), and use of the optically pure compound of formula (I) or a pharmaceutically acceptable salt or hydrate thereof as a medicament, in particular as a medicament for the treatment and prevention of type B hepatitis. | 01-07-2010 |
20100087448 | Dihydropyrimidine Compounds and Their Uses in Preparation of Medicaments for Treating and Preventing Antiviral Diseases - The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt or hydrate thereof, to a process for preparing the compound of formula (I), and to use of the compound of formula (I) or a pharmaceutically acceptable salt or hydrate thereof as a medicament, in particular as a medicament for the treatment and prevention of type B hepatitis. | 04-08-2010 |
20110178141 | Thiazoliums and Their Use for Treating Protein Aging Associated Diseases - The present invention relates to a composition of a thiazolium compound of formula I or a solvate thereof, wherein the definitions of groups in the formula I are as those given in the claims: | 07-21-2011 |
20150117537 | SCALED VIDEO FOR PSEUDO-ANALOG TRANSMISSION IN SPATIAL DOMAIN - Scaled video for pseudo-analog transmission in the spatial domain is described. Boundaries are determined for M L-shaped chunks of coefficients of at least one frequency-transformed video frame of a group of pictures (GOP). The boundaries are determined based at least on variances of the coefficients of the M L-shaped chunks, such as by reducing or minimizing the sum of the square roots of the variances of the coefficients. Corresponding power scale factors for the M L-shaped chunks are determined based at least partly on the variances of the coefficients of the M L-shaped chunks, and the coefficients of the M L-shaped chunks are scaled using the corresponding power scale factors. The pixel values of the frames (e.g., the frames in the spatial domain) are transmitted on a pseudo-analog channel. At the receiver, retained spatial redundancy enables denoising in the spatial domain prior to de-scaling in the frequency domain. | 04-30-2015 |
20150124908 | Fast Decoding based on ZigZag Deconvolution for Random Projection Code - Multi-level symbols generated by applying a Random Projection Code (RPC) to a source bit sequence are received at a receiver via a noisy channel. The received multi-level symbols are represented in a bipartite graph as constraint nodes connected via weighted edges to binary variable nodes that represent the source bit sequence. A decoder uses ZigZag deconvolution to generate constraint node messages as part of an iterative belief propagation to decode the source bit sequence from the received multi-level symbols. | 05-07-2015 |